Home
About
Management / Consultants
Scientific / Corporate Advisors
Board of Directors
Pipeline
Overview
Ibezapolstat
ACX-375C
Publications
News & Media
Press Releases
Presentations
Videos
Investors
Overview
News / Events
Company Information
Financial Information
Stock Data
SEC Filings
Corporate Governance
Ph2 Clinical Trial
Contact
All SEC Filings
Investors
Overview
News / Events
Overview
Press Releases
IR Calendar
Email Alerts
Company Info
Overview
Presentations
Management Team
Contacts
FAQ
Financial Info
Overview
Financial Results
Balance Sheet
Income Statement
Cash Flow
Stock Data
Quote
Charts
Historical Data
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Board Diversity Matrix
Investor Tools
Email Alerts
Contacts
RSS News Feed
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Filing Type:
View All
10-K
10-Q
3
4
424B4
424B5
8-A12B
8-K
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
S-1
S-1/A
S-3
S-8
SC 13D
UPLOAD
Year:
View All
2022
2021
2020
2019
2018
Date
Form
Description
PDF
XBRL
Pages
06/22/21
CORRESP
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
1
06/11/21
FWP
Filing under Securities Act Rules 163/433 of free writing prospectuses
22
06/11/21
S-1/A
General form of registration statement for all companies including face-amount certificate companies
Documents
EX-1.1
EX-5.1
179
05/27/21
S-1
General form of registration statement for all companies including face-amount certificate companies
Documents
EX-1.1
EX-2.1
EX-3.1
EX-3.2
EX-3.3
EX-4.1
EX-5.1
EX-10.1
EX-10.2
EX-10.3
EX-10.4
EX-10.5
EX-10.6
EX-10.7
EX-10.8
EX-10.9
EX-10.10
EX-10.11
EX-23.1
EX-99.1
EX-99.2
EX-99.3
EX-99.4
304
05/26/21
CORRESP
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
1
05/21/21
UPLOAD
SEC-generated letter
Documents
TEXT-EXTRACT
2
05/10/21
DRSLTR
Correspondence Related to Draft Registration Statement
4
05/10/21
DRS/A
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Documents
EX-2.1
EX-3.1
EX-3.2
EX-3.3
EX-10.1
EX-10.2
EX-10.3
EX-10.5
EX-10.10
EX-10.11
EX-99.1
EX-99.2
EX-99.3
EX-99.4
235
04/30/21
UPLOAD
SEC-generated letter
Documents
TEXT-EXTRACT
5
04/05/21
DRS
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
134
1
2
3
4
5
6
7